Exclusive: FBI agents raid headquarters
of major U.S. body broker
Send a link to a friend
[November 08, 2017]
By John Shiffman and Brian Grow
PORTLAND, Oregon (Reuters) - Federal agents
have seized records from a national company that solicits thousands of
Americans to donate their bodies to science each year, then profits by
dissecting the parts and distributing them for use by researchers and
educators.
The search warrant executed by the Federal Bureau of Investigation at
MedCure Inc headquarters here on November 1 is sealed, and the bureau
and the company declined to comment on the nature of the FBI
investigation. But people familiar with the matter said the inquiry
concerns the manner in which MedCure distributes body parts acquired
from its donors.
MedCure is among the largest brokers of cadavers and body parts in the
United States. From 2011 through 2015, documents obtained under
public-record laws show, the company received more than 11,000 donated
bodies and distributed more than 51,000 body parts to medical industry
customers nationally. In a current brochure, the company says that
80,000 additional people have pledged to donate their bodies to MedCure
when they die.
FBI spokeswoman Beth Anne Steele confirmed the day-long search of the
25,000-square-foot facility, but declined to comment further because the
matter is under seal. A person familiar with the matter said that FBI
agents took records from MedCure but did not remove human remains.
The search warrant, though sealed, signals that an FBI investigation of
MedCure has reached an advanced stage. To obtain a search warrant to
seize records, rather than demand them via subpoena, FBI agents must
provide a detailed affidavit to a U.S. magistrate with evidence to
support probable cause that crimes have been committed and that related
records may be on the premises.
“MedCure is fully cooperating with the FBI, and looks forward to
resolving whatever questions the government may have about their
business,” said Jeffrey Edelson, a Portland attorney who represents the
company. “Out of respect for the integrity of the process, we do not
believe that further comment is appropriate at this time.”
[to top of second column] |
The headquarters of MedCure, one of the nation's largest body
brokers, raided by FBI agents last week conducting a search warrant,
is shown outside Portland, Oregon, November 6, 2017. REUTERS/John
Shiffman
It is illegal to profit from the sale of organs destined for
transplant, such as hearts and kidneys. But as a Reuters series
detailed last month, it is legal in most U.S. states to sell donated
whole bodies or their dissected parts, such as arms and heads, for
medical research, training and education.
Commonly known as body brokers, these businesses often profit by
targeting people too poor to afford a burial or cremation. Reuters
documented how people who donate their bodies to science may be
unwittingly contributing to commerce. Few states regulate the body
donation industry, and those that do so have different rules,
enforced with varying degrees of thoroughness. Body parts can be
bought with ease in the United States. A Reuters reporter bought two
heads and a spine from a Tennessee broker with just a few emails.
MedCure, founded in 2005, is based outside Portland, Oregon, and has
offices in Nevada, Florida, Rhode Island and Missouri, as well as
Amsterdam, the Netherlands. At some locations, including the one
near Portland, MedCure provides training labs for doctors and health
professionals to practice surgical techniques. MedCure also sends
body parts and technicians to assist with medical conferences across
the country.
MedCure is accredited by the American Association of Tissue Banks, a
national organization that primarily works with transplant tissue
banks. The broker is also licensed by the state health departments
in Oregon and New York, among the few states that conduct
inspections. According to Oregon state health records, officials
renewed MedCure’s license in January, following a routine on-site
review.
(Edited by Michael Williams)
[© 2017 Thomson Reuters. All rights
reserved.]
Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |